Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices

Completed

• Conditions: Blood Stream Infections; MRSA Infections
• Interventions: Behavioral: healthcare staff processes for infection prevention

• Registration Number: NCT01255943
• Lead Sponsor: MaineHealth

Brief Summary

The purpose of this study is to implement strategies for improved efficiency and waste reduction ("Toyota Lean") and positive deviance, a social behavioral change process, utilizing frontline healthcare personnel to reduce infection bloodstream infection and MRSA infection in outpatient dialysis care. In two outpatient dialysis units, dialysis unit healthcare staff will be educated in Toyota lean techniques and conduct periodic "discovery and action" dialogues to identify and implement care process changes to reduce infection. Outcomes to be monitored will include incidence of bloodstream infections and MRSA infections of all types. Data will be assessed at quarterly intervals using interrupted time series analysis.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07
• Study First Submitted: 2010-12-06
• Study First Submitted QC: 2010-12-07
• Study First Posted: 2010-12-08
• Primary Completion: 2012-04
• Study Completion: 2012-04
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-08
• Last Update Posted: 2021-11-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 175

Inclusion Criteria

all hemodialysis patients at two outpatient dialysis units

Read More

Exclusion Criteria

peritoneal dialysis patients

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
prevalent hemodialysis patients	healthcare staff processes for infection prevention	These patients are observed in two outpatient dialysis units with a combined census of approximately 175 patients

Primary Outcome Measures

Name	Time	Method
Incidence of bloodstream infections	14 months

Secondary Outcome Measures

Name	Time	Method
Incidence of MRSA infections	14 months

Trial Locations

Locations (1)

Maine Medical Center; 🇺🇸 Portland, Maine, United States